Lorlatinib (PF-06463922)
Lorlatinib (PF-06463922) 是一种强效的双重 ALK/ROS1 抑制剂,其 Ki 值分别为 ROS1 <0.02 nM、ALK (WT) <0.07 nM 和 ALK (L1196M) 0.7 nM。
Lorlatinib (PF-06463922) 是一种强效的双重 ALK/ROS1 抑制剂,其 Ki 值分别为 ROS1 <0.02 nM、ALK (WT) <0.07 nM 和 ALK (L1196M) 0.7 nM。
Discription | Lorlatinib (PF-06463922) is a potent, dual ALK/ROS1 inhibitor with Ki of <0.02 nM, <0.07 nM, and 0.7 nM for ROS1, ALK (WT), and ALK (L1196M), respectively. |
|||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A14207 |
---|---|
分子式 | C21H19FN6O2 |
分子量 | 406.41 |
CAS号 | 1454846-35-5 |
SMILES | C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C |
其他名称 | PF 06463922, PF06463922 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | Warmed: 70 mg/mL (172.23 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 26 mg/mL | ||
In vivo | 2% DMSO+30% PEG 300+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.61 mL | 123.03 mL | 246.06 mL |
0.5 mM | 4.92 mL | 24.61 mL | 49.21 mL |
1 mM | 2.46 mL | 12.3 mL | 24.61 mL |
5 mM | 0.49 mL | 2.46 mL | 4.92 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2